The multifaceted role of ferroptosis in liver disease

J Chen, X Li, C Ge, J Min, F Wang - Cell Death & Differentiation, 2022 - nature.com
Ferroptosis is an iron-dependent form of non-apoptotic cell death characterized by
excessive lipid peroxidation and associated with a plethora of pathological conditions in the …

Overview of iron metabolism in health and disease

S Dev, JL Babitt - Hemodialysis International, 2017 - Wiley Online Library
Iron is an essential element for numerous fundamental biologic processes, but excess iron is
toxic. Abnormalities in systemic iron balance are common in patients with chronic kidney …

β-Thalassemia

R Origa - Genetics in Medicine, 2017 - nature.com
Abstract β-Thalassemia is caused by reduced (β+) or absent (β 0) synthesis of the β-globin
chains of hemoglobin. Three clinical and hematological conditions of increasing severity are …

Iron overload in thalassemia: different organs at different rates

AT Taher, AN Saliba - Hematology 2014, the American Society …, 2017 - ashpublications.org
Thalassemic disorders lie on a phenotypic spectrum of clinical severity that depends on the
severity of the globin gene mutation and coinheritance of other genetic determinants. Iron …

Beta-thalassemia

R Galanello, R Origa - Orphanet journal of rare diseases, 2010 - Springer
Beta-thalassemias are a group of hereditary blood disorders characterized by anomalies in
the synthesis of the beta chains of hemoglobin resulting in variable phenotypes ranging from …

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

M Omata, LA Lesmana, R Tateishi, PJ Chen… - Hepatology …, 2010 - Springer
Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …

[HTML][HTML] Beta-thalassemia

A Cao, R Galanello - Genetics in medicine, 2010 - Elsevier
Beta-thalassemia is caused by the reduced (beta+) or absent (beta 0) synthesis of the beta
globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of …

Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association

DJ Pennell, JE Udelson, AE Arai, B Bozkurt… - Circulation, 2013 - Am Heart Assoc
This aim of this statement is to report an expert consensus on the diagnosis and treatment of
cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover …

Iron-chelating therapy for transfusional iron overload

GM Brittenham - New England Journal of Medicine, 2011 - Mass Medical Soc
Iron-Chelating Therapy for Transfusional Iron Overload | New England Journal of Medicine Skip
to main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Survival and complications in thalassemia

C BORGNA‐PIGNATTI, MD Cappellini… - Annals of the New …, 2005 - Wiley Online Library
The life expectancy of patients with thalassemia major has significantly increased in recent
years, as reported by several groups in different countries. However, complications are still …